Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
KEGG | hsa05135 | Yersinia infection | 48/1759 | 137/8135 | 0.0001918 | 0.003051 | 0.002202 | 48 | RABC37 | |
KEGG | hsa04218 | Cellular senescence | 53/1759 | 156/8135 | 0.0002238 | 0.003398 | 0.002452 | 53 | RABC37 | |
KEGG | hsa05160 | Hepatitis C | 53/1759 | 157/8135 | 0.0002682 | 0.003895 | 0.002811 | 53 | RABC37 | |
KEGG | hsa05132 | Salmonella infection | 77/1759 | 249/8135 | 0.000324 | 0.004509 | 0.003254 | 77 | RABC37 | |
KEGG | hsa05340 | Primary immunodeficiency | 18/1759 | 38/8135 | 0.0003686 | 0.004924 | 0.003554 | 18 | RABC37 | |
KEGG | hsa05140 | Leishmaniasis | 30/1759 | 77/8135 | 0.0003954 | 0.00508 | 0.003666 | 30 | RABC37 | |
KEGG | hsa04140 | Autophagy - animal | 48/1759 | 141/8135 | 0.0004124 | 0.005101 | 0.003681 | 48 | RABC37 | |
KEGG | hsa04650 | Natural killer cell mediated cytotoxicity | 45/1759 | 131/8135 | 0.0004938 | 0.00589 | 0.004251 | 45 | RABC37 | |
KEGG | hsa04662 | B cell receptor signaling pathway | 31/1759 | 82/8135 | 0.0005886 | 0.006779 | 0.004892 | 31 | RABC37 | |
KEGG | hsa04620 | Toll-like receptor signaling pathway | 37/1759 | 104/8135 | 0.0007195 | 0.00801 | 0.005781 | 37 | RABC37 | |
KEGG | hsa05145 | Toxoplasmosis | 39/1759 | 112/8135 | 0.0008467 | 0.009122 | 0.006584 | 39 | RABC37 | |
KEGG | hsa03420 | Nucleotide excision repair | 20/1759 | 47/8135 | 0.0009937 | 0.0101 | 0.007286 | 20 | RABC37 | |
KEGG | hsa05142 | Chagas disease | 36/1759 | 102/8135 | 0.0009975 | 0.0101 | 0.007286 | 36 | RABC37 | |
KEGG | hsa04141 | Protein processing in endoplasmic reticulum | 39/949 | 171/8135 | 0.000024 | 0.007842 | 0.007776 | 39 | RABC38 | |
KEGG | hsa04120 | Ubiquitin mediated proteolysis | 33/949 | 142/8135 | 0.0000675 | 0.01104 | 0.01094 | 33 | RABC38 | |
KEGG | hsa05208 | Chemical carcinogenesis - reactive oxygen species | 72/1364 | 223/8135 | 0.00000000623 | 0.00000207 | 0.00000151 | 72 | RABC91 | |
KEGG | hsa05166 | Human T-cell leukemia virus 1 infection | 67/1364 | 222/8135 | 0.000000378 | 0.000063 | 0.000046 | 67 | RABC91 | |
KEGG | hsa04660 | T cell receptor signaling pathway | 36/1364 | 104/8135 | 0.00000688 | 0.0005946 | 0.0004342 | 36 | RABC91 | |
KEGG | hsa05020 | Prion disease | 74/1364 | 273/8135 | 0.00000839 | 0.0005946 | 0.0004342 | 74 | RABC91 | |
KEGG | hsa05014 | Amyotrophic lateral sclerosis | 93/1364 | 364/8135 | 0.00000893 | 0.0005946 | 0.0004342 | 93 | RABC91 | |
KEGG | hsa04658 | Th1 and Th2 cell differentiation | 32/1364 | 92/8135 | 0.0000197 | 0.0009687 | 0.0007074 | 32 | RABC91 | |
KEGG | hsa04010 | MAPK signaling pathway | 77/1364 | 294/8135 | 0.0000211 | 0.0009687 | 0.0007074 | 77 | RABC91 | |
KEGG | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 31/1364 | 89/8135 | 0.0000256 | 0.0009687 | 0.0007074 | 31 | RABC91 | |
KEGG | hsa05169 | Epstein-Barr virus infection | 57/1364 | 202/8135 | 0.0000262 | 0.0009687 | 0.0007074 | 57 | RABC91 | |
KEGG | hsa04932 | Non-alcoholic fatty liver disease | 46/1364 | 155/8135 | 0.0000402 | 0.001271 | 0.0009283 | 46 | RABC91 | |
KEGG | hsa05012 | Parkinson disease | 70/1364 | 266/8135 | 0.0000422 | 0.001271 | 0.0009283 | 70 | RABC91 | |
KEGG | hsa04659 | Th17 cell differentiation | 35/1364 | 108/8135 | 0.0000458 | 0.001271 | 0.0009283 | 35 | RABC91 | |
KEGG | hsa04066 | HIF-1 signaling pathway | 35/1364 | 109/8135 | 0.0000568 | 0.001325 | 0.0009676 | 35 | RABC91 | |
KEGG | hsa05170 | Human immunodeficiency virus 1 infection | 58/1364 | 212/8135 | 0.0000591 | 0.001325 | 0.0009676 | 58 | RABC91 | |
KEGG | hsa05415 | Diabetic cardiomyopathy | 56/1364 | 203/8135 | 0.0000615 | 0.001325 | 0.0009676 | 56 | RABC91 |